glp-1 south africa As Use Expands, Long-Term Safety Questions Remain Under Watch sunpharma #semaglutide #glp1 #genericmedicines #southafrica

Conversely, although off-label use of GLP-1 RA for overweight and obesity cannot be excluded, such use was likely limited in the present study given existing prescription guidelines and regulatory vigilance

It acts on GLP-1 and GIP receptors, which is why it is often described as a dual-action treatment

This includes structured dietary approaches such as portion control, increased protein intake (1.2 to 1.6 grams per kilogram of body weight daily, with caution in chronic kidney disease), and emphasis on whole foods with high satiety value

Patients comfortable with compounded semaglutide can start for as low as $199/month, while those who want Wegovy, Ozempic, or tirzepatide can upgrade (though at higher cost)